Ipilimumab Offers ‘Prolonged’ Survival to Patients with Metastatic Melanoma
Ipilimumab (YERVOY) offers 4- and 5-year survival benefits for patients with metastatic melanoma.
Diagnosis & Disease Information
ESMO: Dabrafenib + Trametinib Significantly Prolongs PFS in Melanoma with BRAF V600 Mutations
Combination dabrafenib and trametinib significantly improved progression-free survival in patients with melanoma and BRAF V600 mutations.
Optical Imaging Shows Promise in 3D Microvascular Mapping of Skin Tumors
Noninvasive optical coherence tomography imaging allow noninvasive mapping of complex microvascular networks in skin, and might become useful in diagnosing and monitoring skin cancer.
PEG-IFN-α-2b Benefits Patients with Ulcerated Melanoma, Microscopic Nodal Disease
Patients with ulcerated melanoma and lower tumor burden had the “greatest benefit” from treatment with adjuvant pegylated interferon alfa-2b.
Skin Cancer Incidence Up After Pancreas Transplantation
Nonmelanoma skin cancers common after pancrea transplant, especially in recipients with prior skin cancer.
Melanoma Transection Doesn’t Affect Overall Survival
Punch and saucerization biopsies more likely to transect tumors than excisional biopsies in melanoma.
Promotion of Sun Safety Does Not Inhibit Outdoor Exercise
Perceived severity of or susceptibility to skin cancer doesn’t reduce children’s outdoor activity.
SPECT/CT Associated With Improved Survival in Melanoma
SPECT/CT-aided sentinel lymph node excision improves detection of metastases, and improved survival in melanoma patients.
Parkinson Disease Linked to Prostate Cancer, Melanoma
A study has found a novel association between Parkinson disease (PD) and prostate cancer and confirmed the reported risk association for melanoma in patients with PD.
Skin Cancer Risk Increased by HPV Infection
Infection with specific subtypes of human papillomavirus (HPV) is a risk factor for squamous cell carcinoma (SCC) of the skin.
- Loading...
Loading...
Loading... 
Loading...